Levocetirizine Dihydrochloride Tablet, Coated
Product Images NDC 63868-473

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 63868-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Marketing Association Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Packaging label for Levocetirizine Dihydrochloride Tablets USP, 5 mg by Chain Drug Marketing Association INC. The label indicates 35 coated tablets containing the antihistamine active ingredient levocetirizine dihydrochloride for oral use. The label includes dosage directions, warnings, inactive ingredients, and a customer service contact number.*

FDA Label Image

Carton (Carton)

Packaging label for Levocetirizine Dihydrochloride Tablets USP, 5 mg, an antihistamine oral coated tablet. The label shows original prescription strength tablets in a 35-tablet package by Quality Choice, distributed by Chain Drug Marketing Association INC. The label includes directions for use, warnings, inactive ingredients, and Drug Facts for treating allergy symptoms such as sneezing, runny nose, itchy nose or throat, and watery eyes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.